308 related articles for article (PubMed ID: 32522622)
1. Intact olfactory memory in the 5xFAD mouse model of Alzheimer's disease from 3 to 15 months of age.
O'Leary TP; Stover KR; Mantolino HM; Darvesh S; Brown RE
Behav Brain Res; 2020 Sep; 393():112731. PubMed ID: 32522622
[TBL] [Abstract][Full Text] [Related]
2. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease.
Girard SD; Jacquet M; Baranger K; Migliorati M; Escoffier G; Bernard A; Khrestchatisky M; Féron F; Rivera S; Roman FS; Marchetti E
Hippocampus; 2014 Jul; 24(7):762-72. PubMed ID: 24596271
[TBL] [Abstract][Full Text] [Related]
3. Gad67 haploinsufficiency reduces amyloid pathology and rescues olfactory memory deficits in a mouse model of Alzheimer's disease.
Wang Y; Wu Z; Bai YT; Wu GY; Chen G
Mol Neurodegener; 2017 Oct; 12(1):73. PubMed ID: 29017573
[TBL] [Abstract][Full Text] [Related]
4. Spared piriform cortical single-unit odor processing and odor discrimination in the Tg2576 mouse model of Alzheimer's disease.
Xu W; Lopez-Guzman M; Schoen C; Fitzgerald S; Lauer SL; Nixon RA; Levy E; Wilson DA
PLoS One; 2014; 9(9):e106431. PubMed ID: 25181487
[TBL] [Abstract][Full Text] [Related]
5. Sex and Genotype Differences in Odor Detection in the 3×Tg-AD and 5XFAD Mouse Models of Alzheimer's Disease at 6 Months of Age.
Roddick KM; Roberts AD; Schellinck HM; Brown RE
Chem Senses; 2016 Jun; 41(5):433-40. PubMed ID: 26969629
[TBL] [Abstract][Full Text] [Related]
6. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
7. Prolonged Volatile Anesthetic Exposure Exacerbates Cognitive Impairment and Neuropathology in the 5xFAD Mouse Model of Alzheimer's Disease.
Han F; Zhao J; Zhao G
J Alzheimers Dis; 2021; 84(4):1551-1562. PubMed ID: 34690137
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatments with a 5-HT
Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
[TBL] [Abstract][Full Text] [Related]
9. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model.
Kimura R; Ohno M
Neurobiol Dis; 2009 Feb; 33(2):229-35. PubMed ID: 19026746
[TBL] [Abstract][Full Text] [Related]
10. The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease.
Migliorati M; Manrique C; Rahrah M; Escoffier G; El Ahmadi A; Girard SD; Khrestchatisky M; Rivera S; Baranger K; Roman FS
J Alzheimers Dis; 2022; 90(1):251-262. PubMed ID: 36093693
[TBL] [Abstract][Full Text] [Related]
11. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
[TBL] [Abstract][Full Text] [Related]
12. Diesel engine exhaust accelerates plaque formation in a mouse model of Alzheimer's disease.
Hullmann M; Albrecht C; van Berlo D; Gerlofs-Nijland ME; Wahle T; Boots AW; Krutmann J; Cassee FR; Bayer TA; Schins RPF
Part Fibre Toxicol; 2017 Aug; 14(1):35. PubMed ID: 28854940
[TBL] [Abstract][Full Text] [Related]
13. Age-related deterioration of motor function in male and female 5xFAD mice from 3 to 16 months of age.
O'Leary TP; Mantolino HM; Stover KR; Brown RE
Genes Brain Behav; 2020 Mar; 19(3):e12538. PubMed ID: 30426678
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β deposition and olfactory dysfunction in an Alzheimer's disease model.
Wu N; Rao X; Gao Y; Wang J; Xu F
J Alzheimers Dis; 2013; 37(4):699-712. PubMed ID: 23948910
[TBL] [Abstract][Full Text] [Related]
15. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
Moon M; Cha MY; Mook-Jung I
J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
[TBL] [Abstract][Full Text] [Related]
16. Visuo-spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer's disease: Effects of age, sex, albinism, and motor impairments.
O'Leary TP; Brown RE
Genes Brain Behav; 2022 Apr; 21(4):e12794. PubMed ID: 35238473
[TBL] [Abstract][Full Text] [Related]
17. Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.
Mariani MM; Malm T; Lamb R; Jay TR; Neilson L; Casali B; Medarametla L; Landreth GE
Sci Rep; 2017 Feb; 7():42270. PubMed ID: 28205585
[TBL] [Abstract][Full Text] [Related]
18. Clusterin contributes to early stage of Alzheimer's disease pathogenesis.
Oh SB; Kim MS; Park S; Son H; Kim SY; Kim MS; Jo DG; Tak E; Lee JY
Brain Pathol; 2019 Mar; 29(2):217-231. PubMed ID: 30295351
[TBL] [Abstract][Full Text] [Related]
19. Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus.
Crouzin N; Baranger K; Cavalier M; Marchalant Y; Cohen-Solal C; Roman FS; Khrestchatisky M; Rivera S; Féron F; Vignes M
PLoS One; 2013; 8(9):e74667. PubMed ID: 24069328
[TBL] [Abstract][Full Text] [Related]
20. Cognitive benefits of memantine in Alzheimer's 5XFAD model mice decline during advanced disease stages.
Devi L; Ohno M
Pharmacol Biochem Behav; 2016 May; 144():60-6. PubMed ID: 26948858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
